Stoke Therapeutics
STOK
#6250
Rank
NZ$1.08 B
Marketcap
$20.50
Share price
-13.58%
Change (1 day)
161.30%
Change (1 year)

Stoke Therapeutics (STOK) Fails to deliver data

Key failure to deliver metrics for Stoke Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Stoke Therapeutics (STOK) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Stoke Therapeutics (STOK) - since 2019

Volume in USD (price x number of shares), data since 2019

Stoke Therapeutics (STOK) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$8.02 M11.27%
2023NZ$7.21 M-21.67%
2022NZ$9.2 M-23.01%
2021NZ$11.96 M-15.13%
2020NZ$14.09 M2.39%
2019NZ$13.76 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
NZ$1.5 MNZ$5.99 M๐Ÿ‡บ๐Ÿ‡ธ USA